Abstract:Heart disease is a worldwide health menace. Both intractable primary and secondary cardiomyopathies contribute to malignant cardiac dysfunction and mortality. One of the key cellular processes associated with cardiomyopathy is cardiomyocyte death. Cardiomyocytes are terminally differentiated cells with very limited regenerative capacity. Various insults can lead to irreversible damage of cardiomyocytes, contributing to progression of cardiac dysfunction. Accumulating evidence indicates that majority of cardiomyocyte death is executed by regulating molecular pathways, including apoptosis, ferroptosis, autophagy, pyroptosis, and necroptosis. Importantly, these forms of regulated cell death (RCD) are cardinal features in the pathogenesis of various cardiomyopathies, including dilated cardiomyopathy, diabetic cardiomyopathy, sepsis-induced cardiomyopathy, and drug-induced cardiomyopathy. The relevance between abnormity of RCD with adverse outcome of cardiomyopathy has been unequivocally evident. Therefore, there is an urgent need to uncover the molecular and cellular mechanisms for RCD in order to better understand the pathogenesis of cardiomyopathies. In this review, we summarize the latest progress from studies on RCD pathways in cardiomyocytes in context of the pathogenesis of cardiomyopathies, with particular emphasis on apoptosis, necroptosis, ferroptosis, autophagy, and pyroptosis. We also elaborate the crosstalk among various forms of RCD in pathologically stressed myocardium and the prospects of therapeutic applications targeted to various cell death pathways.

Editorial: Cytokines, novel cell death models and pathways in cardiovascular diseases

Editorial: Autophagy-Mediated Cell Survival and Death in Disease Progression and Treatment

Epigenetic Regulation of Diverse Regulated Cell Death Modalities in Cardiovascular Disease:Insights into Necroptosis, Pyroptosis, Ferroptosis, and Cuproptosis

Editorial: Insights in Cardiovascular Therapeutics 2022—cardiovascular Innate Immunity

Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches

Editorial: Modeling of cardiovascular systems

Regulated cell death pathways in cardiomyopathy

Editorial: Liver diseases and programmed cell death.

Small Molecules, Big Effects: the Role of Micrornas in Regulation of Cardiomyocyte Death

Editorial: Common pathogenic mechanism of cerebrovascular disease and degenerative diseases.

PANoptosis: Novel insight into regulated cell death and its potential role in cardiovascular diseases (Review)

Non-coding RNAs in necroptosis, pyroptosis, and ferroptosis in cardiovascular diseases

Editorial for the Molecular Genetics and Genomics of Metabolic Disorders in Cardiovascular and Cerebrovascular Diseases Special Issue: June 2023.

Editorial: Bioengineered gene and cell therapy for treating cardiovascular diseases.

Editorial: Epigenetic Regulation in Cardiovascular Diseases, Volume II

Editorial: New Mechanisms and Drugs for the Treatment of Cardiovascular Disease with Diabetes

Early growth response-1: Key mediators of cell death and novel targets for cardiovascular disease therapy

Editorial: Computational Biomechanics of the Heart and Vasculature with Potential Clinical and Surgical Applications

Programmed Cell Death: Complex Regulatory Networks in Cardiovascular Disease

Editorial: Advances of endocrine and metabolic cardiovascular outcomes: From basic to clinical science, volume II

Advances in Cell Death Mechanisms Involved in Viral Myocarditis